Searched for
IMMUNOSUPPRESSIVE THERAPIES
Concord Biotech shares jump 8% on USFDA nod for Mycophenolate Mofetil oral suspensionConcord Biotech shares saw a significant jump on Wednesday. This surge followed the company's announcement of receiving approval from the U...- Could space-grown stem cells unlock faster cancer treatments and revolutionize organ regeneration breakthroughs? NASA’s ISS experiments are revealing surprising answers about the power of microgravity medicineSpace stem cell research is rapidly changing cancer treatment and regenerative medicine worldwide. Scientists aboard the International Spac...
- RPG Life Sciences bets big on API business, eyes GLP-1 entry by August-SeptemberRPG Life Sciences is prioritizing its API business for future growth, planning a significant acquisition to scale operations. The company a...
- Tattoos causing you vision loss? Researchers warn tattoos may trigger rare condition, even years laterAn Australian study has identified 40 new cases of tattoo-associated uveitis, doubling global reports and highlighting a rare, sight-threat...
- Breakthrough in China: Stem cell therapy achieves efficiency in Parkinson's recoveryChinese scientists have developed a groundbreaking stem cell therapy for Parkinson's disease. Their treatment serves an impressive self-pro...
- A cure for type-1 diabetes is within reach: Breakthrough stem cell therapies show promise in 2025Hope is on the horizon for Type-1 diabetes patients. New stem cell therapies are showing remarkable progress. These treatments aim to repla...
- Venus Remedies gets new market authorisations for drugs in VietnamPharma major Venus Remedies has received new marketing authorisations in Vietnam for its drugs Methotrexate, Cefuroxime, and Irinotecan. Th...
- Scientists transplant genetically modified pig lung into human for first timeIn a groundbreaking achievement, Chinese researchers successfully transplanted a genetically modified pig lung into a brain-dead man. The l...
- AstraZeneca's COVID prevention drug cuts risk of disease in vulnerable patientsAstraZeneca's COVID-19 prevention therapy, sipavibart, has shown a significant reduction in symptomatic COVID-19 cases among immunocompromi...
- Concord Biotech's niche API play holds promise for growthET Intelligence Group: Ahmedabad-based Concord Biotech is a global supplier of bio-pharmaceutical APIs and formulations, serving more than ...
- ICMR national protocol says no evidence of benefit of injectable steroids in patients not requiring oxygenThe revised guidance updated on January 14 also warns of potential risk of fungal infections such as invasive mucormycosis, if anti-inflamm...
- Covid: NTAGI discusses administering 'additional' vaccine dose, inoculation of kidsAnswering a list of frequently asked questions (FAQs) about the Omicron variant of coronavirus, the Health Ministry has said that while the...
- Centre issues guidelines for management of black fungus in kids below 18"Remdesivir, an emergency use authorisation drug, is not recommended in children," the guideline said.
- 65 yr old man becomes 1st Covid patient to get antibody cocktail at Apollo in DelhiAs part of this single dose infusion-based treatment, patients with mild to moderate symptoms, are offered a cocktail of Casirivimab and Im...
- Centre issues advisory on management of Mucormycosis fungal infection in COVID-19 patientsWarning symptoms include pain and redness around eyes and nose, fever, headache, coughing, shortness of breath, bloody vomits and altered m...
- Health Ministry adds steroid dexamethasone in COVID-19 treatment protocolThe updated protocol includes the advice to use dexamethasone as an alternative choice to methylprednisolone for managing moderate to sever...
- Panacea Biotec enters collaboration with Bionpharma for generics worth $800 millionShare prices spiked upon the development, going as high as 9.75% (Rs 148 a piece) on the Bombay Stock Exchange before 11:00 am on Friday.
- Zydus Group clinches in-licensing deal with Swiss company Neovii"The Zydus group will market this therapy through Zydus Trans-immune, a division that offers a range of therapies related to transplant med...
- Pharma cos focus on specialist therapiesPharma cos's emphasis is shifting to more focused therapies for specific cancers, immunological conditions and complex diseases.
- Biocon forays into nephrology spaceThe new immunosuppressants for renal therapy are at least 35-40 per cent cheaper than the MNC drug prices in the similar product category.
Load More
